Biomarker panels for predicting prostate cancer outcomes
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 10, 2019
Grant Date -
Jan 14, 2016
app pub date -
Sep 17, 2015
filing date -
May 30, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This document provides methods and materials related to assessing male mammals (e.g., humans) with prostate cancer. For example, methods and materials for predicting (1) which patients, at the time of PSA reoccurrence, will later develop systemic disease, (2) which patients, at the time of retropubic radial prostatectomy, will later develop systemic disease, and (3) which patients, at the time of systemic disease, will later die from prostate cancer are provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully